MYD88 and cancer: MyD88, a pivotal signaling molecule, has garnered attention for its dysregulated expression in various cancer types, including colorectal cancer (23), ovarian cancer (24), hepatocellular carcinoma (25), and pancreatic cancer (26), highlighting its role in tumor progression.